MRC Centre for Drug Safety Science, Department of Pharmacology & Therapeutics, University of Liverpool, Sherrington Buildings, Ashton Street, Liverpool L693GE, UK.
Toxicol Sci. 2009 Dec;112(2):521-31. doi: 10.1093/toxsci/kfp235. Epub 2009 Sep 25.
Drug-induced hepatotoxicity represents a major clinical problem and an impediment to new medicine development. Serum biomarkers hold the potential to provide information about pathways leading to cellular responses within inaccessible tissues, which can inform the medicinal chemist and the clinician with respect to safe drug design and use. Hepatocyte apoptosis, necrosis, and innate immune activation have been defined as features of the toxicological response associated with the hepatotoxin acetaminophen (APAP). Within this investigation, we have unambiguously identified and characterized by liquid chromatography-tandem mass spectrometry differing circulating molecular forms of high-mobility group box-1 protein (HMGB1) and keratin-18 (K18), which are linked to the mechanisms and pathological changes induced by APAP in the mouse. Hypoacetylated HMGB1 (necrosis indicator), caspase-cleaved K18 (apoptosis indicator), and full-length K18 (necrosis indicator) present in serum showed strong correlations with the histological time course of cell death and was more sensitive than alanine aminotransferase activity. We have further identified a hyperacetylated form of HMGB1 (inflammatory indicator) in serum, which indicated that hepatotoxicity was associated with an inflammatory response. The inhibition of APAP-induced apoptosis and K18 cleavage by the caspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp(OMe) fluoromethyl ketone are associated with increased hepatic damage, by a shift to necrotic cell death only. These findings illustrate the initial verification of K18 and HMGB1 molecular forms as serum-based sensitive tools that provide insights into the cellular dynamics involved in APAP hepatotoxicity within an inaccessible tissue. Based on these findings, potential exists for the qualification and measurement of these proteins to further assist in vitro, in vivo, and clinical bridging in toxicological research.
药物性肝毒性是一个主要的临床问题,也是新药开发的障碍。血清生物标志物有可能提供关于导致细胞反应的途径的信息,这些信息可以为药物化学家提供信息,同时为临床医生提供关于安全药物设计和使用的信息。肝细胞凋亡、坏死和固有免疫激活已被定义为与肝毒素对乙酰氨基酚(APAP)相关的毒性反应的特征。在这项研究中,我们通过液相色谱-串联质谱法明确地鉴定和描述了高迁移率族蛋白 B1(HMGB1)和角蛋白 18(K18)的不同循环分子形式,这些分子形式与 APAP 在小鼠中诱导的机制和病理变化有关。血清中低乙酰化的 HMGB1(坏死标志物)、半胱天冬酶切割的 K18(凋亡标志物)和全长 K18(坏死标志物)与细胞死亡的组织学时间进程呈强相关性,比丙氨酸氨基转移酶活性更敏感。我们还在血清中鉴定出一种高乙酰化形式的 HMGB1(炎症标志物),表明肝毒性与炎症反应有关。半胱天冬酶抑制剂 N-苄氧羰基-Val-Ala-Asp(OMe)氟甲基酮抑制 APAP 诱导的凋亡和 K18 切割与肝损伤增加有关,仅导致坏死性细胞死亡。这些发现说明了 K18 和 HMGB1 分子形式作为基于血清的敏感工具的初步验证,这些工具提供了对不可触及组织中 APAP 肝毒性所涉及的细胞动力学的深入了解。基于这些发现,有可能对这些蛋白质进行定性和测量,以进一步协助毒理学研究中的体外、体内和临床桥接。